The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-7-(4-Amino-2-fluorophenyl)-N-(azepan-3-yl)isoquinolin-5-amine ID: ALA4635482
PubChem CID: 156014126
Max Phase: Preclinical
Molecular Formula: C21H23FN4
Molecular Weight: 350.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ccc(-c2cc(N[C@H]3CCCCNC3)c3ccncc3c2)c(F)c1
Standard InChI: InChI=1S/C21H23FN4/c22-20-11-16(23)4-5-18(20)14-9-15-12-25-8-6-19(15)21(10-14)26-17-3-1-2-7-24-13-17/h4-6,8-12,17,24,26H,1-3,7,13,23H2/t17-/m0/s1
Standard InChI Key: NTJHXOPWIGBYGG-KRWDZBQOSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
6.3655 -6.0789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6575 -6.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6575 -7.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3680 -7.7157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0738 -7.3051 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0738 -6.4856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9481 -7.7220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2356 -7.3080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2330 -6.4898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9409 -6.0740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9409 -5.2545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2328 -4.8469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2099 -4.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5555 -3.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7677 -3.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4290 -4.4863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8028 -5.2120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6091 -5.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5275 -7.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5272 -8.5352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8175 -8.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1091 -8.5365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1069 -7.7187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8151 -7.3055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8151 -6.4860 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.4011 -8.9441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
5 4 1 0
6 5 2 0
1 6 1 0
3 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
2 10 1 0
10 11 1 0
12 11 1 6
13 12 1 0
13 14 1 0
14 15 1 0
16 15 1 0
17 16 1 0
18 17 1 0
12 18 1 0
19 8 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
24 25 1 0
22 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 350.44Molecular Weight (Monoisotopic): 350.1907AlogP: 4.18#Rotatable Bonds: 3Polar Surface Area: 62.97Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.84CX LogP: 2.72CX LogD: 0.34Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.62Np Likeness Score: -0.65
References 1. Atobe M, Serizawa T, Yamakawa N, Takaba K, Nagano Y, Yamaura T, Tanaka E, Tazumi A, Bito S, Ishiguro M, Kawanishi M.. (2020) Discovery of 4,6- and 5,7-Disubstituted Isoquinoline Derivatives as a Novel Class of Protein Kinase C ζ Inhibitors with Fragment-Merging Strategy., 63 (13): [PMID:32551607 ] [10.1021/acs.jmedchem.0c00449 ] 2. de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L.. (2022) Fragment-to-Lead Medicinal Chemistry Publications in 2020., 65 (1.0): [PMID:34928151 ] [10.1021/acs.jmedchem.1c01803 ]